Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady

All NewsApril 10, 2026

FDA accepts Telix NDA for Pixclara for brain cancer imaging, analysts see confidence rebuild amid steady sales growth.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Gnosis Pay breach exposes card details, personal data and crypto wallet information

US Treasury cuts off MEXC over alleged $16B in illicit transactions

U.S. Treasury Cuts Off MEXC From U.S. Financial System Over Alleged $16 Billion in Illicit Flows

Cathie Wood buys $47 million of popular semiconductor stock

Amazon is selling $15 touchscreen-friendly gloves that make the perfect stocking stuffer